Poly (Lactic-Co-Glycolic Acid) (PLGA) Market - Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Composition Coverage, By Application Coverage, By Geographic Coverag

Poly (Lactic-Co-Glycolic Acid) (PLGA) Market - Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Composition Coverage, By Application Coverage, By Geographic Coverage and Leading Companies)

Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Set to Surge with a Remarkable 13% CAGR by 2030, Projected to Reach US$2 Billion

In a recent market analysis, the global poly (lactic-co-glycolic acid) (PLGA) market is expected to experience substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 13% during the assessment period from 2023 to 2030. By the end of 2030, the market's total value is anticipated to approach a significant milestone of US$2 billion.

Driving Factors:

The burgeoning interest in biodegradable and bioresorbable materials within the medical and pharmaceutical industries is a primary driver of this market's expansion. PLGA, being a biocompatible polymer capable of breaking down harmlessly within the body, is widely used in applications such as tissue engineering, surgical sutures, and drug delivery systems. Additionally, the development of PLGA-based microspheres and nanoparticles has facilitated precise and controlled drug release, leading to enhanced therapeutic outcomes.

The versatility of PLGA, including its customizable degradation rate and mechanical strength, has allowed it to adapt to various applications. PLGA's demand has also surged in the cosmetics and personal care sectors, where it is utilized for encapsulating active ingredients, gradually releasing vitamins, antioxidants, and other beneficial substances.

Key Report Findings

• The PLGA market is expected to witness over three-fold revenue growth between 2023 and 2030.

• Fracture fixation, driven by the biocompatibility and biodegradability of PLGA sutures, was a key segment in 2022.

• PLGA 50:50, with a market share exceeding 42.6% in 2022, is the preferred composition.

• North America dominated the market in 2022, holding a share of approximately 35.9%.

Growth Drivers

1. Biomedical Advancements and Demand for Drug Delivery Systems: PLGA's biodegradable and biocompatible nature has made it indispensable in drug encapsulation and controlled release applications. The pursuit of personalized medicine has driven the use of PLGA-based microspheres and nanoparticles for precise dosing and extended release of pharmaceutical compounds.

2. Eco-friendly and Sustainable Material Solutions: As environmental concerns grow, the biodegradability and biocompatibility of PLGA have garnered significant attention, particularly in fields like agriculture and packaging. PLGA-based materials are being explored as alternatives to conventional plastics in packaging, aligning with the principles of the circular economy. In agriculture, PLGA-based formulations are seen as eco-friendly solutions for controlled-release fertilizers and pesticides.

3. Expansion of Nanotechnology: The development of PLGA nanoparticles with precise sizes for targeted drug delivery and imaging applications has opened up new possibilities in medical treatments. Beyond the medical and cosmetic sectors, PLGA finds applications in agriculture, food packaging, and electronics due to its eco-friendly and sustainable properties.

Key Segments:

• Growing Application in Medical Industry: Fracture fixation, especially in the form of PLGA sutures, is a significant application due to its biocompatibility and biodegradability, reducing the need for suture removal and lowering infection risk.

• Cosmetics and Dermatology: PLGA's use in encapsulating active ingredients for skincare products is growing rapidly, enhancing the effectiveness of skincare formulas.

• PLGA 50:50: This balanced composition, with equal parts of polyglycolic acid (PGA) and polylactic acid (PLA), is the dominant category due to its versatility, suitable for applications ranging from tissue engineering to drug delivery.

• PLGA 75:25: This composition, with a higher PLA-to-PGA ratio, is preferred for applications requiring sustained drug release over extended periods, particularly in pharmaceuticals and medical sectors.

Regional Growth Opportunities:

• North America: With a robust pharmaceutical and biotechnology industry, North America is the largest market for PLGA. It prioritizes research and development, leading to the adoption of PLGA-based technologies in personalized medicine, targeted therapeutics, and less invasive procedures.

• Asia Pacific: This region is experiencing the fastest growth in the PLGA market, driven by a booming healthcare and pharmaceutical sector, increased investments in healthcare infrastructure, and a growing population. Contract manufacturing and research organizations (CMOs and CROs) in Asia Pacific are increasingly turning to PLGA for its adaptability and suitability in healthcare applications.

Challenges:

The complexity of formulating and manufacturing PLGA-based products is a significant challenge, as precise control over properties like molecular weight, lactic acid to glycolic acid ratio, and degradation rate is essential for consistent product performance and quality.

Competitive Landscape

Leading players in the poly (lactic-co-glycolic acid) (PLGA) market include Evonik Industries, Polysciences, Inc., DSM, Mitsui Chemicals, Ashland Inc., Creative PEGWorks, Corbion, and Poly-Med Incorporated.

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.